Literature DB >> 308103

Cellular and molecular toxicology of lead. II. Effect of lead on delta-aminolevulinic acid synthetase of cultured cells.

M Kusell, L Lake, M Andersson, L E Gerschenson.   

Abstract

The effect of lead nitrate on delta-aminolevulinic acid synthetase (ALA synthetase), the first and rate-limiting enzyme of the heme biosynthetic pathway, was studied by using an established rat liver cell line (RLC-GAI). Lead was shown to produce a time-dependent increase in ALA synthetase activity, with a maximum after incubation of the cells for 24 h with 10(-5) M lead nitrate. The effect of lead was not liver-specific in that increases in enzyme activity were produced in other tissue-derived cell lines. Cycloheximide but not actinomycin D, cordycepin, or hydroxyurea, at concentrations that inhibit the synthesis of protein, RNA, and DNA, prevented the lead-associated increase in ALA synthetase activity. Heme, added to the cells as hemin, also prevented the effect of lead. These results indicate that lead induced the synthesis of ALA synthetase secondary to an inhibition of the synthesis of heme.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308103     DOI: 10.1080/15287397809529675

Source DB:  PubMed          Journal:  J Toxicol Environ Health        ISSN: 0098-4108


  3 in total

1.  Acute lead poisoning in inherited porphobilinogen synthase (delta-aminolevulinic acid dehydrase) deficiency.

Authors:  M Doss; W A Müller
Journal:  Blut       Date:  1982-08

2.  Persistent protoporphyrinemia in hereditary porphobilinogen synthase (delta-aminolevulinic acid dehydrase) deficiency under low lead exposure. A new molecular basis for the pathogenesis of lead intoxication.

Authors:  M Doss; U Becker; F Sixel; S Geisse; H Solcher; J Schneider; G Kufner; H Schlegel; M Stoeppler
Journal:  Klin Wochenschr       Date:  1982-06-15

3.  Effects of lead treatment on intracellular iron and copper concentrations in cultured astroglia.

Authors:  E Tiffany-Castiglioni; J Zmudzki; J N Wu; G R Bratton
Journal:  Metab Brain Dis       Date:  1987-03       Impact factor: 3.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.